Tech Company Financing Transactions
Mercator Therapeutics Funding Round
On 8/11/2010, Mercator Therapeutics received $2 million in funding from private investors.
Transaction Overview
Company Name
Announced On
8/11/2010
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
22 Auburn Rd.
Wellesley, MA 02481
USA
Wellesley, MA 02481
USA
Phone
Website
Email Address
Overview
Mercator Therapeutics is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. Mercator was founded to translate the research of Drs. Wadih Arap and Renata Pasqualini into effective cancer therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Guiffre
Browse more venture capital transactions:
Prev: 8/11/2010: dMetrics venture capital transaction
Next: 8/11/2010: Netpulse venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs